Patient perceptions of the re-usable Respimatt® Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study

Michael Dreher; David Price; Asparuh Gardev; Pascale Peeters; Satish Arora; Simone van der Sar-van der Brugge; Richard Dekhuijzen; Omar S Usmani

doi:10.1177/1479973120986228

Patient perceptions of the re-usable Respimatt^® Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study

Chron Respir Dis. 2021 Jan-Dec:18:1479973120986228. doi: 10.1177/1479973120986228.

Authors

Michael Dreher¹, David Price^{2

3

4}, Asparuh Gardev⁵, Pascale Peeters⁶, Satish Arora⁷, Simone van der Sar-van der Brugge⁸, Richard Dekhuijzen⁹, Omar S Usmani¹⁰

Affiliations

¹ Department of Pneumology and Intensive Care Medicine, 39058University Hospital Aachen; RWTH Aachen University, Aachen, Germany.
² Observational and Pragmatic Research Institute, Singapore.
³ Optimum Patient Care, Cambridge, UK.
⁴ Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
⁵ 60325Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
⁶ 54886IQVIA RDS France, La Défense, France.
⁷ Lambertseter Medical Centre, Oslo, Norway.
⁸ 89411Amphia Hospital, Breda, The Netherlands.
⁹ 6029Radboud University Medical Center, Nijmegen, The Netherlands.
¹⁰ National Heart and Lung Institute (NHLI), 4615Imperial College London, London, UK.

Abstract

Inhalers are often used to treat patients with chronic obstructive pulmonary disease (COPD). However, there are many available, which can lead to confusion and poor inhaler technique. It is important for a patient to be happy with their inhaler. This study looked at how patients liked the re-usable Respimat® Soft Mist™ inhaler vs. their previous inhaler. It also asked whether they would be willing to continue using the device at the end of the study period.After 4-6 weeks of using the re-usable device, patients reported that they were happy with the inhaler and most would be willing to carry on using it.Overall, these results show that doctors can prescribe Respimat re-usable to patients, even if the patient has not used the inhaler before.

Keywords: COPD; PASAPQ; Respimat; ease of handling; preference; switch.

MeSH terms

Administration, Inhalation
Bronchodilator Agents* / therapeutic use
Humans
Nebulizers and Vaporizers
Perception
Pulmonary Disease, Chronic Obstructive* / drug therapy

Substances

Bronchodilator Agents